Dymista Allergen Chamber - Onset of Action Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study is to assess the onset of action of fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray (Dymista) in treating the nasal symptoms of seasonal allergic rhinitis (SAR) induced by an allergen challenge in an Environmental Exposure Unit (EEU).
Epistemonikos ID: ecec212e6b7471d9ba25d19cc53edff6b3a6c01e
First added on: May 07, 2024